Report on Bioscience Alliances in Silicon Valley
Report on Bioscience Alliances in Silicon Valley will be held on June 7, 2006 at Crowne Plaza Caba
Report on Bioscience Alliances in Silicon Valley will be held on June 7, 2006 at Crowne Plaza Caba
The conference BioImmersion will be held from June 28-30th, 2006 at the Embassy Suites, 150 Anza Blvd, Burlingame, CA 94010. The course introduces and explains the basic biological concepts that are the basis for biotechnology.
The 2006 Venture Forum will be held on June 28-29, 2006 at the San Jose Hilton & Convention Center. The event is heralded as the nation’s largest showcase of seed and early-stage companies.
The conference Assay Development & High Throughput Screening will take place on June 22-23, 2006 at the Marines’ Memorial Club & Hotel in San Francisco, CA. The event will focus on new development in Cell Based Assays and HTS Screenings (New reporter systems, High contents screening, Channels, Yeast: genetic and enzymatic), In vitro Assays and Screening, Applications in Drug Discovery (Target identification and validation, Biomarkers and Diagnostics application), and Data collection and management. Presentations will be given from organizations such as Merck, Eli Lilly, Roche, Pfizer, AstraZeneCa, Amgen, Chiron, GE Global Research Center, Serono and many more. For more information contact Rania Hafez at raniah@gtcbio.com
UCSC Extension in Silicon Valley will teach a course on Bioscience Business Development: Building Value, which begins June 22-23, 2006. This is an exciting array of intensive courses covering the breadth of the bioscience field. From discovery to clinical to market and beyond, the organization helps busy professionals rapidly gain the knowledge they need to keep pace with the dynamic industry. The speakers for this year’s event will include: Ginger Dreger , J.D., M.S., who heads the biotechnology patent prosecution group in the Silicon Valley office of Heller Ehrman; Harold (Hal) Etterman, MBA, who has over 25 years of experience in Finance, Operations and Information Technology, including over ten years serving as a CFO, COO and interim CEO; Carolyn Feamster , MBA, Vice President, Business Strategy & Analysis at Clearview Projects; Thomas L. Gutshall , Chairman as well as Co-Founder of Cepheid in 1996; Michael G. McCully , M.S., Director at Recombinant Capital (Recap); and Herwig von Morze , Ph.D., an international patent consultant with 27 years of corporate patent experience in Europe and the United States.
The conference Assay Development & High Throughput Screening will take place on June 22-23, 2006 at the Marines’ Memorial Club & Hotel in San Francisco, CA. The event will focus on new development in Cell Based Assays and HTS Screenings (New reporter systems, High contents screening, Channels, Yeast: genetic and enzymatic), In vitro Assays and Screening, Applications in Drug Discovery (Target identification and validation, Biomarkers and Diagnostics application), and Data collection and management. Presentations will be given from organizations such as Merck, Eli Lilly, Roche, Pfizer, AstraZeneCa, Amgen, Chiron, GE Global Research Center, Serono and many more. For more information contact Rania Hafez at raniah@gtcbio.com
The 10th Annual Proteomics Conference: Beyond Genome will take place on June 19-21, 2006 at the Fairmont Hotel, San Francisco, CA. The conference will feature programs on Protein Biomarkers for Cancer; Tissue Proteomics-Based Cancer Biomarker Discovery; Analysis of Peptides Associated with Hepatocellular Carcinoma Integrating Genomic and Proteomic Data for Biomarker Discovery; Virtual Mass Spectrometry and the Discovery of Biomarkers; Comparative Proteomics and Genomics Studies for the Discovery of HIV Biomakers; New Proteome Profiling Approaches; High-Throughput Molecular Dissection of an Age Supressing (Klotho) Signaling Pathway using a siRNA Kinome Library and Protein Microarrays; Molecular Network Analysis using Reverse Phase Protein Microarrays for Patient Tailored Therapy; Global Profiling of Protein Tyrosine Phosphatase Activity with Ultra-Sensitive ChemiCal Probes; and Proteomics for Target Identification/Validation. The keynote speakers will include: Dr. Pearl S. Huang, Vice President, Biology, Oncology and Proliferative Disease at GlaxoSmithKline, and Dr. Ellen G. Feigal, Director, Medical Devices and Imaging, The Critical Path Institute.
BayBio2006 will be held on June 15, 2006 from 8:00am – 5:00pm at San Mateo Marriott, 1770 South Amphlett Blvd., San Mateo, California 94402. The conference will highlight the Bay Area’s strength in life sciences product development and commercialization.
The UCSC Extension in Silicon Valley will teach a course on Personalized Medicine: Scientific, Regulatory and Business Dimensions from 8:30 to 5:00 p.m. June 15-16th at the USCS extension classroom campus in Cupertino, CA. The instructors for this course will include: Audrey Erbes, Ph.D., a life science business development and marketing consul
The BIOCOM June Breakfast will be held on June 14, 2006 from 7-9 a.m. at the LaJolla Mariott in San Diego, CA.
Protected by Security by CleanTalk and CleanTalk Anti-Spam